- Home
- ELS vs BMRN Comparison
ELS vs BMRN Comparison
Compare ELS & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELS | BMRN |
|---|---|---|
| Founded | 1992 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 10.5B |
| IPO Year | 1993 | 1999 |
Fundamental Metrics
Financial Performance| Metric | ELS | BMRN |
|---|---|---|
| Price | $61.94 | $53.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 19 |
| Target Price | $70.86 | ★ $88.42 |
| AVG Volume (30 Days) | 1.5M | ★ 3.0M |
| Earning Date | 01-26-2026 | 10-27-2025 |
| Dividend Yield | ★ 3.34% | N/A |
| EPS Growth | 2.36 | ★ 59.53 |
| EPS | 1.99 | ★ 2.68 |
| Revenue | $1,535,911,000.00 | ★ $3,094,001,000.00 |
| Revenue This Year | $1.02 | $13.39 |
| Revenue Next Year | $4.52 | $7.57 |
| P/E Ratio | $30.95 | ★ $19.92 |
| Revenue Growth | 0.93 | ★ 12.39 |
| 52 Week Low | $58.15 | $50.76 |
| 52 Week High | $70.55 | $73.51 |
Technical Indicators
Market Signals| Indicator | ELS | BMRN |
|---|---|---|
| Relative Strength Index (RSI) | 45.91 | 46.19 |
| Support Level | $61.11 | $53.03 |
| Resistance Level | $62.84 | $54.66 |
| Average True Range (ATR) | 0.92 | 1.45 |
| MACD | -0.08 | -0.11 |
| Stochastic Oscillator | 18.86 | 31.61 |
Price Performance
Historical ComparisonAbout ELS Equity Lifestyle Properties Inc.
Equity Lifestyle Properties is a residential REIT that focuses on owning manufactured housing, residential vehicle communities, and marinas. The company currently has a portfolio of 455 properties across the U.S. with a higher concentration in the Sunbelt region with 38% of the company's properties located in Florida, 12% in Arizona, and 8% in California. Equity Lifestyle targets owning properties in attractive retirement destinations with over 70% of the company's properties either being age-restricted or having an average resident age over 55.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.